Next Generation of mRNA Vaccinology: This landscape-changing technology has the potential to be used to manage some of healthcare’s most challenging diseases quickly and efficiently.
Advancements in the generation, purification, and cellular delivery of RNA have enabled the development of mRNA vaccines across a broad array of applications, such as cancer and Zika virus infection. The technology is cost-effective, relatively simple to manufacture, and elicits immunity in a novel way. Furthermore, the emergence of the COVID-19 pandemic demonstrated that the world needed rapid development of a vaccine that was deployable around the globe. Because of previous research that laid the groundwork for this technology, an effective COVID-19 vaccine was developed, produced, approved, and deployed in less than a year. This landscape-changing technology has the potential to be used to manage some of healthcare’s most challenging diseases quickly and efficiently.
Latest from Today's Medical Developments
- Velosity opens precision development center to accelerate medical device product launch
- A look at the latest in the defense industry
- EMCO manufacturing showroom offers customers hands-on milling, machining engagement
- Workholding Roundtable to feature expert insights on a booming market
- Ilika, Cirtec advance strategic partnership to commercial level
- Engineered fluids offer full lifecycle solutions for medical device development
- Syringe-less injector system for diagnostic imaging obtains fourth FDA clearance
- Hohenstein Medical debuts enhanced medical device testing capabilities
